endocrinologist glp-1 Dr. Anand is back to share what you need to know about GLP-1s. The and obesity medicine specialist is here to discuss healthy maintenance habits for your weight loss journey, both GLP-1 for Weight Loss and

Cell type- and etiology-specific regulatory blank spots: Most research centers on renal TECs, but the role of non-parenchymal renal cells in ferroptosis-mediated AKI-to-CKD transition is largely understudied

Cardiovascular outcomes are under investigation in the SURPASS-CVOT trial, which will determine whether tirzepatide reduces major adverse cardiovascular events in high-risk patients

GLP-1 can mitigate hepatic steatosis and liver inflammatory injury by regulating intrahepatic lipid metabolism

Antibiotics: Patients with SAH are at high risk of bacterial infection, which further contributes to the development of multi-organ failure and mortality [92]

Look at it again and you see the boxes under each option that says OTHER